In this regard, it is important to note that in human cancer, genetic activation of NRF2 follows a tissue specific pattern, whereby the NRF2 pathway is frequently activated in lung tumours, but much less so in colorectal and pancreatic tumours [2]. This evidence concerns the gene NFE2L2 and cancer.